FDA Inspection Yields Insight Into Biocon/Mylan Biosimilars Manufacturing Challenges
Executive Summary
Biocon's Bangalore, India, biosimilars manufacturing operation needs quick fix to meet goal dates for pegfilgrastim and trastuzumab in US, even as it works to restore GMP compliance for EU marketing authorization.